WAT
Diagnostics & Research · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Waters Corp publishes a filing, an earnings call transcript or a press release.
Get WAT alertsAmol Chaubal is recorded as CFO at Waters Corp (WAT). Earlier roles on record: CFO at Quanterix Corp (QTRX) until May 11, 2021. The proxy statement of Waters Corp reports total compensation of $2,659,812 for Amol Chaubal in fiscal 2023, including a base salary of $563,750. Disclosed compensation is on record for 5 fiscal years. Amol Chaubal has spoken on 23 earnings calls across 2 companies, most recently for Waters Corp on August 4, 2026. Those appearances were for Waters Corp (WAT) and Quanterix Corp (QTRX). Waters Corp is classified in the Diagnostics & Research industry within the Healthcare sector. Other companies whose calls Amol Chaubal spoke on are classified in the Healthcare sector. Other leadership on record at Waters Corp includes Christopher J (CEO), Dr. Udit Batra (CEO), Keeley A. Aleman (General Counsel) and 7 others.
“So on the BD raise, we are raising the underlying by about 25 million, and then that's partially offset by stronger US dollar by about 15.”
“In the fourth quarter, we delivered a strong finish to the year with as-reported sales and adjusted EPS landing at the high end of our guidance. Sales of $932 million grew 7% as reported and 6% in constant currency.”
“In the third quarter, we delivered sales of $800 million, up 8% as reported and 8% in constant currency. Momentum remained strong with as reported sales increasing 4% quarter-over-quarter, while orders continued to outpace shipments leading to backlog growth.”
“In the second quarter, we delivered sales of $771 million, up 9% as reported and 8% in constant currency. Orders outpaced sales, reflecting solid momentum and setting us up well for further strength in the second half of the year.”
“For the first quarter, we delivered sales of $662 million, up 4% on a reported basis and 7% in constant currency, placing us at the high end of our guidance range.”
Start not stated–2021-05-11
WAT
Diagnostics & Research · Healthcare
CFO
QTRX
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Waters Corp (WAT) | Senior Vice President and Chief Financial Officer | $563,750 | $2,659,812 |
| 2022 | Waters Corp (WAT) | Senior Vice President and Chief Financial Officer | $533,663 | $3,132,263 |
| 2021 | Waters Corp (WAT) | Senior Vice President and Chief Financial Officer | $300,000 | $2,487,435 |
| 2020 | Quanterix Corp (QTRX) | Chief Financial Officer | $371,188 | $1,226,920 |
| 2019 | Quanterix Corp (QTRX) | Chief Financial Officer | $253,077 | $1,343,425 |